The Syneos Health Podcast

The Syneos Health Podcast

The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.... Show More

Episodes

Traditionally, Medical Affairs has served as a support function in later phases of product development, but they now need to play a more strategic and value-based role within the organization – and that means earlier and deeper engagement.

In part three of our Medical Affairs Series, Suma Ramadas, Senior Managing Director and Read more

Share
Mark as Played
October 24, 2019 32 min

Patients have been at the forefront of many of healthcare’s most historic moments—not just as subjects, but also as catalysts for change. Some of today’s advocates look to the early ACT UP years for inspiration; others turn to blueprints established by pioneers like Abbey Meyers or Kathy Guisti. 

In this episode, Keri McDonough, Lead, Advoca... Read more

Share
Mark as Played

No industry standard currently exists to measure value and impact of medical affairs, and the traditional metrics that companies often use to determine return on investment (ROI) simply don’t apply.

In this second episode in our Medical Affairs series, Josh Samon, Managing Director and Read more

Share
Mark as Played
September 24, 2019 20 min

Why do people make good (and bad) decisions about their health? How can we help motivate them to change and give them the resilience to try and try again? Our industry and our world are obsessed with those questions right now.

Kathleen Starr, PhD, Managing Director, Behavioral Insights and Read more

Share
Mark as Played

Medical Affairs, once considered a support function, now has a seat at the table as one of the major pillars of biopharmaceutical organizations.  So now what?  Our new Medical Affairs series, which will unfold over the next several months, will explore what’s next and provide insights and best practices for “Next Gen” Medical Affairs. 

In this first episode of the series, Read more

Share
Mark as Played

The need for real world evidence is growing beyond its original footprint of post-market intelligence, with uses now including regulatory approval, proof of value, maximized access and more.  However, without a true understanding of the regulatory requirements around real world evidence, there is a risk of a “Goldilocks effect”— gathering either not enough information, the wrong information, or far more information than they nee... Read more

Share
Mark as Played
August 14, 2019 19 min

Creating and supporting productive, motivated and happy teams is an ongoing challenge in today’s global workplace – and particularly in the fast-paced biopharmaceutical marketplace.  Incentives can differ based on region, culture, or individual.  Approaches can hinge on countless variables beyond compensation – although in some cases, cash is king.  So what’s the key to success?

Based on 25 years of experience developing c... Read more

Share
Mark as Played
July 31, 2019 19 min

There are dozens of software-driven products under regulatory review for diagnosing, treating, or preventing medical conditions, defining an entirely new sector for the life sciences industry.

Today we are joined by Allison Murphy, Vice President, Business Development, Selling Solutions at Syneos Health and Read more

Share
Mark as Played
July 17, 2019 23 min

Not that kind of pie.  In this case, PIE – or Preapproval Information Exchange – refers to the communication of clinical and health care economic information on therapies in development between U.S. population health decision makers and drug manufacturers prior to regulatory approval.  

John Seay, Vice President and Content Expert, Managed Markets... Read more

Share
Mark as Played

Oncology continues to be one of the hottest therapeutic areas in the biopharmaceutical industry, but one that also poses some of the greatest challenges to developers.

 Jessica Lee, Ph.D., Managing Director in the Commercial Advisory Group at Read more

Share
Mark as Played

When it comes to clinical trials, what do clinical psychologists bring to the table?

Quite a lot, says Alexandria Wise-Rankovic, Ph.D., a clinical psychologist and Senior Vice President, Clinical Development in the CNS Business Unit at Syneos Health.  In this episode, Dr. Wise-Rankovic discusses the important role of the clinical psychologist in... Read more

Share
Mark as Played

The biopharmaceutical market has evolved quite a bit over the last five to 10 years.  As more emerging companies are opting to commercialize on their own, they can no longer look to the “tried and true,” traditional strategies for bringing a therapy to market – those rules no longer apply.  So what’s the new normal, and what does it mean for this new generation of developers?

Read more

Share
Mark as Played

The infrastructure we rely on to create new medicines is in sore need of an upgrade. More and more investigational drugs are streaming into the pipeline. But most of them fail in clinical trials, draining corporate resources, disappointing investors, and shattering the hopes of patients.  Financially speaking, return on investment (ROI) for R&D in biopharma is at an Read more

Share
Mark as Played

Research in the area of live biotherapeutics has exploded in the last seven years. There is still much to learn about whether a dysregulated gut microbiome (dysbiosis) causes disease, or whether disease leads to dysbiosis – but the potential for significant contribution to healthcare is there. 

Erin Mistry, Senior Managing Director, and Read more

Share
Mark as Played

The role of Medical Affairs has changed dramatically in China over the last 10-15 years, moving from what was once considered a secondary support function to one now at the forefront of a more patient-centric paradigm.

Sam Ying, Vice President and General Manager for Syneos Health Commercial in China, discusses the evolution of the Medical Affairs function in China, the rise of the Medical Science Liaison (MSL) and other c... Read more

Share
Mark as Played

The art of communications in the pharmaceutical industry is becoming more complex.

According to Amy Hutnik, Chief Growth and Transformation Officer for Syneos Health Communications, we’ve evolved from the point of DTC (Direct to Consumer) to the extremely individualize... Read more

Share
Mark as Played

New regulations, which were adopted on May 26, 2017, will affect all device and diagnostics manufacturers looking to sell products in the EU, with stricter requirements being introduced in order for these products to be approved.  We are just over a year out from implementation of some of these European Union Medical Device Regulations (EUMDR), set for May 2020.  With the deadline looming, how prepared should manufactur... Read more

Share
Mark as Played
March 28, 2019 16 min

In this first episode of the Syneos Health Podcast: APAC Edition, host Robbie Chana speaks with Sebastian Bather, President of APAC in Japan for Syneos Health, about key trends in Asia Pacific with potentially high impact on the biopharmaceutical industry in the region, includ... Read more

Share
Mark as Played

According to the Syneos Health 2019 Health Trend Ten, perhaps the biggest shift for 2019 and beyond is global focus on understanding what product differentiation looks like in real-world environments.  In Europe in particular, countries are implementing more stringent measures that will impact how value is assigned in the future – and real world eviden... Read more

Share
Mark as Played

Big changes are happening in Asia, opening up a world of possibilities for biopharmaceutical companies to accelerate clinical development of innovative medicines.

Robbie Chana, Vice President, Business Development, Asia Pacific talks about the unique opportunity for biopharma in the region, such as regulatory and financial incentives for innova... Read more

Share
Mark as Played

Chat About The Syneos Health Podcast

Popular Podcasts

The Joe Rogan Experience
The Joe Rogan Experience
Joe Rogan's Weekly Podcast
Bad Batch
Bad Batch
Patients in search of a miracle cure end up in critical condition. The race is on to find out what went wrong before more people get hurt. The trail leads back to a medical company with slick marketing and a charismatic CEO. And to a multibillion dollar stem cell industry where greed and desperation collide. Laura Beil, the award-winning host and reporter of “Dr Death,” returns for this six-part investigative series from Wondery, the makers of “Dirty John” and “The Shrink Next Door.”
The Ron Burgundy Podcast
The Ron Burgundy Podcast
Will Ferrell reprises his role as Ron Burgundy in his brand new Ron Burgundy Podcast! Each episode has a different theme in which Ron engages in conversation with another notable person on the topic at hand.